Cti Biopharm Corp
(CTIC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,209 | 30,420 | 32,048 | 66,091 | 96,902 |
| Marketable Securities | 34,802 | 49,519 | 49,591 | 29,779 | N/A |
| Receivables | 22,957 | 15,387 | 10,592 | 8,159 | 2,426 |
| Inventories | 777 | 733 | 1,147 | 702 | 102 |
| TOTAL | $86,453 | $99,396 | $96,935 | $107,372 | $103,283 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 0 | 0 | 44 |
| Intangibles | 22,705 | 23,226 | 23,757 | 24,289 | 24,815 |
| Other Non-Current Assets | 3,114 | 3,303 | 2,774 | 2,873 | 3,293 |
| TOTAL | $25,819 | $26,529 | $26,531 | $27,162 | $28,152 |
| Total Assets | $112,272 | $125,925 | $123,466 | $134,534 | $131,435 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 48,084 | 47,943 | 0 | 0 | 47,521 |
| Accounts payable and accrued liabilities | 2,025 | 2,008 | 2,443 | 3,097 | 2,425 |
| Accrued Expenses | 16,306 | 29,402 | 26,574 | 25,967 | 47,039 |
| Other current liabilities | 1,811 | 1,781 | 753 | 725 | 1,947 |
| TOTAL | $68,226 | $81,134 | $29,770 | $29,789 | $98,932 |
| Non-Current Liabilities | |||||
| Long Term Debt | 68,371 | 61,134 | 108,093 | 107,378 | 58,587 |
| Other Non-Current Liabilities | 1,022 | 1,234 | 2,440 | 2,641 | 1,833 |
| TOTAL | $69,393 | $62,368 | $110,533 | $110,019 | $60,420 |
| Total Liabilities | $137,619 | $143,502 | $140,303 | $139,808 | $159,352 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 131,880 | 131,836 | 126,894 | 114,385 | 108,967 |
| Common Shares | 132 | 131 | 127 | 114 | 101 |
| Retained earnings | -2,532,329 | -2,518,907 | -2,501,449 | -2,485,744 | -2,463,090 |
| Other shareholders' equity | -11 | -35 | -89 | -71 | 0 |
| TOTAL | $-25,347 | $-17,577 | $-16,837 | $-5,274 | $-27,917 |
| Total Liabilities And Equity | $112,272 | $125,925 | $123,466 | $134,534 | $131,435 |